Anthem Company Profile (NYSE:ANTM)

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

Anthem declared a quarterly dividend on Thursday, April 27th. Investors of record on Friday, June 9th will be paid a dividend of $0.65 per share on Friday, June 23rd. This represents a $2.60 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend is Wednesday, June 7th. View Anthem's Dividend History.

Anthem, Inc. (NYSE:ANTM) released its quarterly earnings data on Wednesday, April, 26th. The company reported $4.68 earnings per share for the quarter, beating analysts' consensus estimates of $3.85 by $0.83. The company earned $22.32 billion during the quarter, compared to analyst estimates of $21.23 billion. Anthem had a net margin of 3.19% and a return on equity of 13.13%. The firm's revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.46 earnings per share. View Anthem's Earnings History.

Anthem is scheduled to release their next quarterly earnings announcement on Wednesday, July, 26th 2017. View Earnings Estimates for Anthem.

Anthem updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided EPS guidance of <$11.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.57. The company issued revenue guidance of $88.0-89.0 billion, compared to the consensus revenue estimate of $87.02 billion.

19 brokers have issued twelve-month price targets for Anthem's stock. Their forecasts range from $132.00 to $228.00. On average, they expect Anthem's stock price to reach $173.44 in the next year. View Analyst Ratings for Anthem.

Here are some recent quotes from research analysts about Anthem stock:

• 1. Cantor Fitzgerald analysts commented, "On Thursday, May 11, 2017, the Delaware Chancery Court ruled against Anthem and allows Cigna to terminate the merger agreement with Anthem. The ruling has no impact on our investment thesis, as we assigned a very low probability to Anthem’s ability to complete the merger." (5/11/2017)
• 2. UBS AG analysts commented, "This afternoon, ANTM presented at a healthcare investor conference. The company reaffirmed its full-year 2017 EPS outlook of "at least" $11.50 but noted that the current consensus does not accurately reflect the quarterly seasonality. For example, last year, 1Q EPS included a $0.70 of EPS drag related to one extra day (leap year impact), which becomes a Y/Y tailwind this year in 1Q. Additionally, ANTM is adopting the new accounting standard associated with the stock options & stock-based compensation, which will add $0.10 to ANTM's EPS in 1Q17. Overall, ANTM expects its 1Q to represent 35-40% of its full-year EPS in 2017, compared with 31.5% in 2016. We are adjusting our model accordingly. We are raising our 1Q17 EPS estimate to $4.16 from $3.60, previously (our full-year 2017 EPS estimate remains unchanged at $11.60). Our 1Q17 EPS estimate now represents 36% of our full-year 2017 EPS est." (3/16/2017)
• 3. Jefferies Group LLC analysts commented, "ANTM has managed better volume growth (3.4%) than its Commercial-risk heavy member mix would have suggested. That will slow in '17. P&L-wise, Medicare now is on much better footing, but Medicaid is a mixed bag - improvement in Iowa offset by Expansion rate headwinds. We missed the catchup trade on valuation, but aren't compelled to step in here." (2/2/2017)
• 4. According to Zacks Investment Research, "Anthem’s earnings of $2.45 per share missed the Zacks Consensus Estimate by 1.6% and  declined 10.3% year over year owing to higher expenses. Anthem’s wide product portfolio, divestitures, prudent capital management, modest cash position, strategic acquisitions and ACO arrangements position it for long-term growth. Anthem has recently received high Medicare Star Quality Ratings from the Centers for Medicare & Medicaid Services (CMS). However, Anthem faces increasing regulatory hurdles from the U.S. Department of Justice (DOJ) over its proposed merger with Cigna and has been sued for the same. Though the company will challenge the case, the deal might fall apart and will lead to payment of $1.85 billion in severance charges to Cigna. Also, declining investment income, high debt levels and a weak public exchange business pose risks." (11/7/2016)

Some companies that are related to Anthem include Aetna (AET), Cigna Corporation (CI), Humana (HUM), Centene Corporation (CNC), WellCare Health Plans (WCG), Magellan Health (MGLN), Triple-S Management Corporation (GTS), Catamaran Corp (CTRX), Catamaran Corp (SXCI) and Universal American (UAM).

Anthem's management team includes the folowing people:

• Joseph R. Swedish, Chairman of the Board, President, Chief Executive Officer
• John E. Gallina, Chief Financial Officer, Executive Vice President
• Jose D. Tomas, Chief Human Resource Officer, Executive Vice President
• Gloria M. McCarthy, Executive Vice President, Chief Administrative Officer
• Thomas C. Zielinski, Executive Vice President, General Counsel
• Brian T. Griffin, Executive Vice President, President - Commercial and Specialty Business
• Peter D. Haytaian, Executive Vice President, President of Government Business Division
• Craig E. Samitt M.D., Executive Vice President and Chief Clinical Officer
• Ronald W. Penczek, Senior Vice President, Chief Accounting Officer, Controller
• George A. Schaefer Jr., Lead Independent Director

Anthem's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include APG Asset Management N.V. (0.59%), Focused Investors LLC (0.29%), Tesco Pension Investment Ltd (0.28%), Bank of Montreal Can (0.18%), PGGM Investments (0.14%) and AMF Pensionsforsakring AB (0.13%). Company insiders that own Anthem stock include Gloria M Mccarthy, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Ronald W Penczek, Thomas C Zielinski, Wayne S Deveydt and William J Ryan. View Institutional Ownership Trends for Anthem.

Anthem's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Focused Investors LLC, Swarthmore Group Inc., Factory Mutual Insurance Co., Armstrong Shaw Associates Inc. CT, Rockefeller Financial Services Inc., Oakbrook Investments LLC and BB&T Corp. Company insiders that have sold Anthem stock in the last year include Gloria M Mccarthy, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Ronald W Penczek, Thomas C Zielinski and William J Ryan. View Insider Buying and Selling for Anthem.

Anthem's stock was bought by a variety of institutional investors in the last quarter, including Tesco Pension Investment Ltd, Barometer Capital Management Inc., First Quadrant L P CA, Bank of Montreal Can, James Investment Research Inc., Aperio Group LLC, DnB Asset Management AS and National Pension Service. View Insider Buying and Selling for Anthem.

Shares of Anthem can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Anthem stock can currently be purchased for approximately $191.00.